FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of pharmaceutics and deals with pharmaceutical compositions based on organic concentrate for prevention and treatment of transplant rejection, treatment of autoimmune and allergic diseases, which includes 2-amino-1,3-propanediol compounds, selected from 2-amino-2-[4-(3-benzyloxyphenoxy)-2-chlorophenyl]propyl-1,3-propanediol, 2-amino-2-[4-(3-benzyloxyphenylthio)-2-chlophenyl]propyl-1,3-propanediol, 2-amino-4-(4-heptyloxyphenyl)-2-methyl-butanol and (2R)-2-amino-4-[3-(4-cyclohexyloxybutyl)-benzo[b]thien-6-yl]butan-1-ol in organic solvent, containing 0-78.9% (wt/vol) of ethanol in propylene glycol or 40-83% (wt/vol) of organic component in water, where organic component contains 10-90 wt/fractions of ethanol and 10-90 wt fractions of propylene glycol, methods of their obtaining and introduction.
EFFECT: obtaining pharmaceutical compositions, based on organic concentrate, for prevention and treatment of transplant rejection.
19 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
2-AMINO-1,3-PROPANEDIOL COMPOSITIONS | 2005 |
|
RU2402324C2 |
LIQUID COMPOSITIONS | 2006 |
|
RU2428180C2 |
LIQUID FORMULATIONS | 2006 |
|
RU2470631C2 |
PHARMACEUTICAL COMPOSITION EXHIBITING IMPROVED FLOWABILITY, DRUG PREPARATION, METHOD FOR PREPARING AND USING | 2012 |
|
RU2496486C1 |
COURSE OF TREATMENT WITH APPLICATION OF RECEPTOR S1P AGONIST | 2005 |
|
RU2478384C2 |
USING SIP RECEPTOR MODULATORS IN OPHTHALMOLOGY | 2006 |
|
RU2497513C2 |
USING SIP RECEPTOR MODULATOR | 2008 |
|
RU2498796C2 |
S1P RECEPTOR MODULATORS FOR MULTIPLE SCLEROSIS TREATMENT | 2007 |
|
RU2617502C2 |
SIP RECEPTOR MODULATORS FOR TREATING MULTIPLE SCLEROSIS | 2007 |
|
RU2495664C2 |
METHOD FOR PREPARING PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2475236C2 |
Authors
Dates
2012-12-10—Published
2010-06-17—Filed